Skip to content

Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy

Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy 1

Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol. J Eur Acad Dermatol Venereol 2012 May;26 Suppl 3:47-51. With the introduction of topical corticosteroids, a milestone has been achieved in dermatologic therapy; owing to its potent anti-inflammatory and ant proliferative effects, it became possible to treat some hitherto resistant dermatoses. In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers. A systematic review of risk of adrenal suppression and skin atrophy. The use of topical corticosteroids for long durations may increase the risk of local cutaneous AEs, including skin atrophy and, infrequently, adrenal suppression. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.

Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy 2Allergy; corticosteroids; foam vehicle; medication adherence; psoriasis; topical therapy; vitamin D Semin Cutan Med Surg 35(supp2):S35-S46 2016 Frontline Medical Communications. 20 A systematic review of 13 published studies on psoriasis concluded that in patients who used topical corticosteroids for a period of 4 weeks to 1 year, the risk of skin atrophy was seen in 0 to 5 of patients. However, none of the studies showed any evidence of clinically significant HPA axis suppression due to absorption of topical steroids. Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:47-51. Topical corticosteroids are the cornerstone of treatment for the majority of psoriasis patients. Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.

Conclusion: No clinically relevant HPA axis or calcium homeostasis impact was observed with 4 weeks of once-daily Cal/BD foam in patients with extensive psoriasis vulgaris. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. Corticosteroid therapy may be effective, but its use is limited due to its dose- and time-dependent side effects, including risk of adrenal axis suppression, skin atrophy, tachyphylaxis, striae, rosacea-like symptoms, perioral dermatitis, acne, and purpura. 10 Corticosteroid therapy may be effective, but its use is limited due to its dose- and time-dependent side effects, including risk of adrenal axis suppression, skin atrophy, tachyphylaxis, striae, rosacea-like symptoms, perioral dermatitis, acne, and purpura. Review article. Plaque psoriasis is the most common form, accounting for approximately 90 of cases.

Global Academy For Medical Education: Topical Therapies For Psoriasis: Improving Management Strategies And Patient Adherence

Topical use of glucocorticoids can lead to the development of skin atrophy which is characterized by reduced skin thickness and elasticity, telangiectasia and purpura 3. Castela E, Archier E, Devaux S, Gallini A, Aractingi S, Cribier B et al (2012) Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol. 2008; 158: 754 765CrossRef. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol. Topical treatment with vitamin D analogs and corticosteroids is the mainstay of first-line therapy for patients with localized psoriasis. Dermatologists choose from an array of treatment approaches for their patients with psoriasis, often managing mild to moderate plaque psoriasis with topical therapy. 3Cutaneous or local adverse effects associated with higher-potency corticosteroids include skin atrophy, easily contused skin, purpura, striae, and telangiectasis.

A Novel Aerosol Foam Formulation Of Calcipotriol And Betamethasone Has No Impact On Hpa Axis And Calcium Homeostasis In Patients With Extensive Psoriasis Vulgaris